Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-21

Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy, safety, and tolerability of sarecycline for perioral dermatitis has completed, contributing data on its use fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sarecycline (sarecycline)

Snippet

Sponsor: The Dermatology Institute of Boston | Conditions: Perioral Dermatitis | Phase 4 | Status: COMPLETED